Using the Montreal Cognitive Assessment Scale to screen for dementia in Chinese patients with Parkinson's disease

Shanghai Archives of Psychiatry

Volumn 25, Issue 5, 2013, Pages 296-305

  Chen, Ling ^a   Yu, Cuiyu ^b   Fu, Xiaosu ^a   Liu, Weiguo ^b   Hua, Ping ^b   Zhang, Ning ^b   Guo, Shenghan ^c  

^a Jiangsu Province Official Hospital   (China)

^b THE AFFILIATED BRAIN HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^c Howard Hughes Medical Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84891349760     PISSN: 10020829     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1002-0829.2013.05.005     Document Type: Article

References (34)

1. Pagonabarraga J, Kulisevsky J. Cognitive impairment and dementia in Parkinson's disease. Neurobiol Dis 2012; 46(3): 590-596.
2. Aarsland D, Zaccai J, Brayne C. A systematic review of prevalence studies of dementia in Parkinson's disease. Mov Disord 2005; 20(10): 1255-1263.
3. Nussbaum M, Treves T A, Inzelberg R, Rabey J M, Korczyn A D. Survival in Parkinson's disease: the effect of dementia. Parkinsonism Relat Disord 1998; 4(4): 179-181.
4. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th Edition. Washington, DC: American Psychiatric Association, 1994.
5. Martinez-Martin P, Falup-Pecurariu C, Rodriguez-Blazquez C, Serrano-Dueñas M, Carod Artal F J, Rojo Abuin J M, et al. Dementia associated with Parkinson's disease: applying the Movement Disorder Society Task Force criteria. Parkinsonism Relat Disord 2011; 17(8): 621-624.
6. Dubois B, Burn D, Goetz C, Aarsland D, Brown R G, Broe G A, et al. Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force. Mov Disord 2007; 22(16): 2314-2324.
7. Gibb W R, Lees A J. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1988; 51(6): 745-752.
8. Zhang M Y. Handbook of Scales Used in Psychiatry. Changsha: Hunan Science and Technology Press; 1998. p. 166-168. (in Chinese)
9. Zadikoff C, Fox S H, Tang-Wai D F, Thomsen T, de Bie R M, Wadia P, et al. A comparison of the mini mental state exam to the Montreal cognitive assessment in identifying cognitive deficits in Parkinson's disease. Mov Disord 2008; 23(2): 297-299.
10. Dong Y, Sharma V K, Chan B P, Venketasubramanian N, Teoh H L, Seet R C, et al. The Montreal Cognitive Assessment (MoCA) is superior to the Mini-Mental State Examination (MMSE) for the detection of vascular cognitive impairment after acute stroke. J Neurol Sci 2010; 299(1): 15-18.
11. Fujiwara Y, Suzuki H, Yasunaga M, Sugiyama M, Ijuin M, Sakuma N, et al. Brief screening tool for mild cognitive impairment in older Japanese: validation of the Japanese version of the Montreal Cognitive Assessment. Geriatr Gerontol Int 2010; 10(3): 225-232.
12. Lee J Y, Dong W L, Cho S J, Na D L, Hong J J, Maeng J C. Brief screening for mild cognitive impairment in elderly outpatient clinic: validation of the Korean version of the Montreal Cognitive Assessment. J Geriatr Psychiatry Neurol 2008; 21(2): 104-110.
13. Wong A, Xiong Y Y, Kwan P W, Chan A Y, Lam W W, Wang K, et al. The validity, reliability and clinical utility of the Hong Kong Montreal Cognitive Assessment (HK-MoCA) in patients with cerebral small vessel disease. Dement Geriatr Cogn Disord 2009; 28(1): 81-87.
14. Rossetti H C, Lacritz L H, Cullum C M, Weiner M F. Normative data for the Montreal Cognitive Assessment (MoCA) in a population-based sample. Neurology 2011; 77(21): 1272-1275.
15. Hu J B, Zhou W H, Hu S H, Huang M L, Wei N, Qi H L, et al. Cross-cultural difference and validation of the Chinese version of Montreal Cognitive Assessment in older adults residing in Eastern China: preliminary findings. Arch Gerontol Geriatr 2013; 56(1): 38-43.
16. Wang X D (ed). Rating Scales for Mental Health, revised edition. Beijing: Chinese Journal of Mental Health Press; 1999. p. 196-199. (in Chinese)
17. Mickes L, Jacobson M, Peavy G, Wixted J T, Lessig S, Goldstein J L, et al. A comparison of two brief screening measures of cognitive impairment in Huntington's disease. Mov Disord 2010; 25(13): 2229-2233.
18. United Parkinson's Disease Rating Scale (UPDRS version 3.0) Chinese Journal of Geriatrics 1999; 18(1): 61-62. (in Chinese)
19. Chaudhuri K R, Martinez-Martin P, Schapira A H, Stocchi F, Sethi K, Odin P, et al. International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson's disease: The NMSQuest study. Mov Disord 2006; 21(7): 916-923
20. Chaudhuri K R, Pal S, DiMarco A, Whately-Smith C, Bridgman K, Mathew R, et al. The Parkinson's disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson's disease. J Neurol Neurosurg Psychiatry 2002; 73(6): 629-635.
21. Zhang M Y. Handbook of Scales Used in Psychiatry. Changsha: Hunan Science and Technology Press; 1998. p.35-39. (in Chinese)
22. Wang Z Y, Chi Y F. Zung self-rating Depression Scale (SDS). Shanghai Archives of Psychiatry 1984; 2: 71-72. (in Chinese)
23. Wang Z Y, Chi Y F. Zung self-rating Anxiety Scale (SAS). Shanghai Archives of Psychiatry 1984; 2: 73-74. (in Chinese)
24. Fluss R, Faraggi D, Reiser B. Estimation of the Youden Index and its associated cutoff point. Biom J 2005; 47(4): 458-472.
25. Fleiss J L, Levin B, Paik M C. Statistical Methods for Rates and Proportions, 3rd Edition. Hoboken, New Jersey: John Wiley & Sons; 2003.
26. Dong Y, Lee W Y, Basri N A, Collinson S L, Merchant R A, Venketasubramanian N, et al. The Montreal Cognitive Assessment is superior to the Mini-Mental State Examination in detecting patients at higher risk of dementia. Int Psychogeriatr 2012; 24(11): 1749-1755.
27. Hoops S, Nazem S, Siderowf A D, Duda J E, Xie S X, Stern M B, et al. Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease. Neurology 2009; 73(21): 1738-1745.
28. Wang C S, Pai M C, Chen P L, Hou N T, Chien P F, Huang Y C. Montreal Cognitive Assessment and Mini-Mental State Examination performance in patients with mild-to-moderate dementia with Lewy bodies, Alzheimer's disease, and normal participants in Taiwan. Int Psychogeriatr 2013; Aug 7: 1-10. (Epub ahead of print)
29. Nazem S, Siderowf A D, Duda J E, Have T T, Colcher A, Horn S S, et al. Montreal cognitive assessment performance in patients with Parkinson's disease with "normal" global cognition according to mini-mental state examination score. J Am Geriatr Soc 2009; 57(2): 304-308.
30. Emre M, Aarsland D, Brown R, Burn D J, Duyckaerts C, Mizuno Y, et al. Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord 2007; 22(12): 1689-1707.
31. Burn D J, Rowan E N, Allan L M, Molloy S, O'Brien J T, McKeith I G. Motor subtype and cognitive decline in Parkinson's disease, Parkinson's disease with dementia, and dementia with Lewy bodies. J Neurol Neurosurg Psychiatry, 2006; 77(5): 585-589.
32. Levy G, Tang M X, Cote L J, Louis E D, Alfaro B, Mejia H, et al. Motor impairment in PD: relationship to incident dementia and age. Neurology 2000; 55(4): 539-544.
33. Aarsland D, Kurz M W. The epidemiology of dementia associated with Parkinson's disease. Brain Pathol 2010; 20(3): 633-639.
34. Levy G, Jacobs D M, Tang M X, Côté L J, Louis E D, Alfaro B, et al. Memory and executive function impairment predict dementia in Parkinson's disease. Mov Disord 2002; 17(6): 1221-1226.